INS and hepatocellular carcinoma: In a meta-analysis of 5 cohort and 9 case–control studies, insulin treatment was associated with a RR for HCC of 1.90 (95% CI, 1.44-2.50) versus noninsulin users.107 The potential bias of longer follow-up was not excluded.